FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150438862> ?p ?o ?g. }

• W3150438862 endingPage "2954" @default.
• W3150438862 startingPage "2946" @default.
• W3150438862 abstract "Glioma-targeted drug delivery is a hugely challenging task because of the multibarrier in the brain. In this study, we report a magnetic T7 peptide&AS1411 aptamer-modified microemulsion for triple glioma-targeted delivery of shikonin and docetaxel (Fe3O4@T7/AS1411/DTX&SKN-M). Such a system comprises two tumor-targeted ligands (T7 peptide and AS1411 aptamer), ultra-small superparamagnetic iron oxide nanoparticle (Fe3O4), and shikonin&docetaxel-coloaded microemulsion (SKN&DTX-M). Fe3O4@T7/AS1411/DTX&SKN-M is capable of stably circulating in the blood, accumulating around the brain under an external magnetic field, distributing inside the glioma via the affinity to nucleolin/transferrin receptor, and retarding the growth of orthotopic glioma. Fe3O4@T7/AS1411/DTX&SKN-M encapsulated Fe3O4 nanoparticles in the core to obtain the superparamagnetism, which did not influence the main surface properties. Introducing 6% (wt%) of DSPE-PEG2000-T7 and 180 nM of AS1411 collaboratively enhanced the murine glioma (G422) cellular uptake of Fe3O4@T7/AS1411/DTX&SKN-M and thereby achieved the strongest antiproliferation among all the groups. Notably, the drug distribution at the brain sites of orthotopic Luc-G422 glioma tumor-bearing nude mice treated with Fe3O4@T7/AS1411/DTX&SKN-M was overwhelming among all the treatments. Most importantly, Fe3O4@T7/AS1411/DTX&SKN-M not only significantly reduced the luminescence signal at the brain areas of orthotopic Luc-G422 glioma mice but also prolonged the overall survival period. The enhancement of anti-glioma efficacy was associated with down-regulating the population of CD133- and CD44-positive cells within the tumors. In summary, such a triple glioma-targeted delivery of shikonin and docetaxel using combinational magnetism and T7/AS1411 modification strategies provides a promising method for synergistic and precise glioma therapy." @default.
• W3150438862 created "2021-04-13" @default.
• W3150438862 creator A5014449026 @default.
• W3150438862 creator A5022095900 @default.
• W3150438862 creator A5033020983 @default.
• W3150438862 creator A5038987580 @default.
• W3150438862 creator A5058775119 @default.
• W3150438862 creator A5086295799 @default.
• W3150438862 date "2021-08-01" @default.
• W3150438862 modified "2023-10-15" @default.
• W3150438862 title "A Magnetic T7 Peptide&AS1411 Aptamer-Modified Microemulsion for Triple Glioma-Targeted Delivery of Shikonin and Docetaxel" @default.
• W3150438862 cites W1964493055 @default.
• W3150438862 cites W2057139597 @default.
• W3150438862 cites W2079140662 @default.
• W3150438862 cites W2080681547 @default.
• W3150438862 cites W2152868824 @default.
• W3150438862 cites W2268074951 @default.
• W3150438862 cites W2410473649 @default.
• W3150438862 cites W2498173628 @default.
• W3150438862 cites W2592308949 @default.
• W3150438862 cites W2598103706 @default.
• W3150438862 cites W2610403529 @default.
• W3150438862 cites W2614794838 @default.
• W3150438862 cites W2615138231 @default.
• W3150438862 cites W2624368609 @default.
• W3150438862 cites W2626252985 @default.
• W3150438862 cites W2742175809 @default.
• W3150438862 cites W2884741638 @default.
• W3150438862 cites W2886422200 @default.
• W3150438862 cites W2894963201 @default.
• W3150438862 cites W2899181479 @default.
• W3150438862 cites W2899462096 @default.
• W3150438862 cites W2899768847 @default.
• W3150438862 cites W2920919700 @default.
• W3150438862 cites W2962751212 @default.
• W3150438862 cites W2965549980 @default.
• W3150438862 cites W2970727614 @default.
• W3150438862 cites W2977444159 @default.
• W3150438862 cites W2990512514 @default.
• W3150438862 cites W2995007636 @default.
• W3150438862 cites W3006191171 @default.
• W3150438862 doi "https://doi.org/10.1016/j.xphs.2021.03.018" @default.
• W3150438862 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33785350" @default.
• W3150438862 hasPublicationYear "2021" @default.
• W3150438862 type Work @default.
• W3150438862 sameAs 3150438862 @default.
• W3150438862 citedByCount "9" @default.
• W3150438862 countsByYear W31504388622021 @default.
• W3150438862 countsByYear W31504388622022 @default.
• W3150438862 countsByYear W31504388622023 @default.
• W3150438862 crossrefType "journal-article" @default.
• W3150438862 hasAuthorship W3150438862A5014449026 @default.
• W3150438862 hasAuthorship W3150438862A5022095900 @default.
• W3150438862 hasAuthorship W3150438862A5033020983 @default.
• W3150438862 hasAuthorship W3150438862A5038987580 @default.
• W3150438862 hasAuthorship W3150438862A5058775119 @default.
• W3150438862 hasAuthorship W3150438862A5086295799 @default.
• W3150438862 hasBestOaLocation W31504388621 @default.
• W3150438862 hasConcept C121608353 @default.
• W3150438862 hasConcept C126322002 @default.
• W3150438862 hasConcept C126511603 @default.
• W3150438862 hasConcept C128972844 @default.
• W3150438862 hasConcept C153911025 @default.
• W3150438862 hasConcept C171250308 @default.
• W3150438862 hasConcept C185592680 @default.
• W3150438862 hasConcept C190119865 @default.
• W3150438862 hasConcept C192562407 @default.
• W3150438862 hasConcept C2778227246 @default.
• W3150438862 hasConcept C2779820397 @default.
• W3150438862 hasConcept C2781190966 @default.
• W3150438862 hasConcept C502942594 @default.
• W3150438862 hasConcept C55493867 @default.
• W3150438862 hasConcept C58226133 @default.
• W3150438862 hasConcept C71924100 @default.
• W3150438862 hasConcept C86803240 @default.
• W3150438862 hasConcept C98274493 @default.
• W3150438862 hasConceptScore W3150438862C121608353 @default.
• W3150438862 hasConceptScore W3150438862C126322002 @default.
• W3150438862 hasConceptScore W3150438862C126511603 @default.
• W3150438862 hasConceptScore W3150438862C128972844 @default.
• W3150438862 hasConceptScore W3150438862C153911025 @default.
• W3150438862 hasConceptScore W3150438862C171250308 @default.
• W3150438862 hasConceptScore W3150438862C185592680 @default.
• W3150438862 hasConceptScore W3150438862C190119865 @default.
• W3150438862 hasConceptScore W3150438862C192562407 @default.
• W3150438862 hasConceptScore W3150438862C2778227246 @default.
• W3150438862 hasConceptScore W3150438862C2779820397 @default.
• W3150438862 hasConceptScore W3150438862C2781190966 @default.
• W3150438862 hasConceptScore W3150438862C502942594 @default.
• W3150438862 hasConceptScore W3150438862C55493867 @default.
• W3150438862 hasConceptScore W3150438862C58226133 @default.
• W3150438862 hasConceptScore W3150438862C71924100 @default.
• W3150438862 hasConceptScore W3150438862C86803240 @default.
• W3150438862 hasConceptScore W3150438862C98274493 @default.
• W3150438862 hasFunder F4320321001 @default.
• W3150438862 hasIssue "8" @default.
• W3150438862 hasLocation W31504388621 @default.
• W3150438862 hasOpenAccess W3150438862 @default.

• next